GlassScriptPhysician profile
Christopher Homsy
NPI 1861747826
$12,173.55
in general payments reported to CMS, 2019-2025
33 companies · $1,953 in 2025
The $1,953 reported for 2025 was more than what 83% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,735 · 2020: $285 · 2021: $2,704 · 2022: $1,981 · 2023: $2,008 · 2024: $1,508 · 2025: $1,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,322 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,322.31 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $2,365.27 | 2022-2025 | Hemoblast Bellows |
| Mentor Worldwide LLC | $1,640.54 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medical Device Business Services, INC. | $1,287.30 | 2021 | |
| Sientra, INC. | $789.41 | 2019-2022 | |
| Biom'Up France Sas | $758.73 | 2020-2021 | |
| Aroa Biosurgery Incorporated | $750.96 | 2023-2025 | |
| Kerecis Limited | $653.52 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $425.25 | 2020-2025 | Integra, Micromatrix, Integra Dermal Regeneration Template |
| Axogen | $383.00 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Tela Bio, INC. | $361.50 | 2019-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kci USA, INC. | $268.92 | 2021-2022 | |
| Stryker Corporation | $240.57 | 2019 | |
| Acera Surgical, INC. | $237.29 | 2024-2025 | Restrata Wound Matrix |
| Guard Medical INC. | $206.37 | 2022 | |
| Polynovo North America LLC | $200.03 | 2019-2025 | Novosorb Btm |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $149.66 | 2021-2025 | Stratafix, Echelon Flex, Proximate |
| W. L. Gore & Associates, INC. | $141.84 | 2021-2024 | Gore Enform Preperitoneal Biomaterial |
| Musculoskeletal Transplant Foundation INC. | $136.15 | 2022-2023 | |
| Biocomposites INC | $132.07 | 2022-2024 | |
| Allergan, INC. | $125.00 | 2019 | |
| Coopersurgical, INC. | $121.34 | 2025 | Onetrac Lx |
| Osiris Therapeutics INC. | $120.56 | 2019 | |
| Insightec,INC | $102.69 | 2023 | Exablate |
| Bolton Medical INC | $91.49 | 2025 | Treo Abdominal Stent-Graft System |
| Smith+Nephew, INC. | $87.24 | 2022-2023 | Collagenase Santyl, Regranex |
| Molnlycke Health Care US, LLC | $77.97 | 2019 | |
| Galderma Laboratories, L.P. | $73.08 | 2019 | |
| Innovation Technologies INC | $71.38 | 2024 | Irrisept |
| Vioptix INC | $51.35 | 2022 | |
| Avita Medical Americas, LLC | $42.71 | 2025 | Permeaderm, Recell, Cohealyx |
| Medtronic, INC. | $29.13 | 2022 | |
| Genzyme Corporation | $25.72 | 2024 | |
| Merck Sharp & Dohme LLC | $25.51 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Homsy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.